טוען...
Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial
BACKGROUND: Dry eye disease (DED) is one of the most common complications following refractive surgery. PURPOSE: Evaluate the efficacy of an osmoprotective eye drop (Optive®) for the management of induced DED in refractive surgery patients. DESIGN: Double-masked randomised controlled trial. METHODS:...
שמור ב:
| הוצא לאור ב: | J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5838485/ https://ncbi.nlm.nih.gov/pubmed/29675272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/4324590 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|